Ashburton Jersey Ltd Has $4.19 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Ashburton Jersey Ltd lowered its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 14.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,043 shares of the biotechnology company’s stock after selling 1,170 shares during the quarter. Axon Enterprise makes up about 1.8% of Ashburton Jersey Ltd’s investment portfolio, making the stock its 19th largest holding. Ashburton Jersey Ltd’s holdings in Axon Enterprise were worth $4,186,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in shares of Axon Enterprise by 3.4% in the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock valued at $5,019,886,000 after purchasing an additional 275,959 shares during the period. Geode Capital Management LLC increased its position in Axon Enterprise by 3.7% during the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company’s stock worth $1,095,542,000 after buying an additional 65,097 shares during the last quarter. Alliancebernstein L.P. raised its stake in Axon Enterprise by 273.8% in the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock valued at $659,128,000 after buying an additional 812,337 shares during the period. Norges Bank acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $482,081,000. Finally, GQG Partners LLC bought a new position in shares of Axon Enterprise during the 4th quarter worth approximately $478,349,000. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on AXON. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Needham & Company LLC restated a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a research note on Wednesday, February 26th. TD Cowen assumed coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. Finally, The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $604.67.

Insider Buying and Selling

In other news, Director Jeri Williams sold 307 shares of the company’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Stock Down 7.9 %

Shares of AXON opened at $497.13 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The firm’s 50 day moving average is $582.26 and its 200-day moving average is $554.66. The stock has a market capitalization of $38.09 billion, a PE ratio of 128.46, a P/E/G ratio of 5.17 and a beta of 1.13.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.